New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities
Contemporary CTD-PAH patients included in REHAP are older and have a lower comorbidity burden than IPAH patients, while exhibiting similar survival rates up to 5 years. CKD is an independent prognostic factor in both aetiologies. CTD-PAH patients tend to receive a more conservative treatment approach.
Authors
- Rafael Bravo Marqués (ORCID: https://orcid.org/0000-0003-2697-2265)
- F Rivas-Ruiz
- Isabel Blanco Vich
- Pedro Antonio Chinchurreta Capote
- Pilar Escribano-subias
- Víctor Becerra
- Elías Ortiz
- Andrés Tenes (ORCID: https://orcid.org/0000-0003-4705-7744)
- Manuel Lopez-Meseguer
- I Martin De Miguel
- the REHAP investigators
- Joan A Barberà
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto Cajal (ES)
- Pulmonary Hypertension Association (US)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Costa del Sol (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Hospital Universitario 12 De Octubre (ES)
- Red de Investigación en Actividades Preventivas y Promoción de la Salud (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Vall d'Hebron Hospital Universitari (ES)
- ERN GUARD-Heart (NL)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1093/rheumatology/keag105
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00